Gowling advises AstraZeneca on Sanofi deal
Experts from the firm’s life sciences group have assisted the global pharmaceutical company, AstraZeneca on a significant transaction. MedImmune, the global biologics research and development arm of AstraZeneca, and Sanofi Pasteur, the vaccines division of Sanofi, announced on 3 March an agreement to develop and commercialise MEDI8897 jointly. MEDI8897 is a monoclonal antibody for the […]